Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F97S1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,318
Award facts
- Contract value 100% obligated
- $22,317.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $22,317.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for GARDASIL 9 syringes (0.5ML) on January 23, 2026, with an ultimate completion date of January 26, 2026. The contract is a non-set-aside award with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.999 billion through December 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to military healthcare systems globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive product portfolio. The company competes on a full and open basis for federal contracts and demonstrates capability across multiple therapeutic domains, including vaccines, specialty medications, and medical supplies. This specific delivery order for GARDASIL 9 vaccine syringes supports the Defense Health Agency's immunization requirements for military personnel and beneficiaries, reflecting the company's ongoing role as a key vendor in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26F97S1?
SPE2DR26F97S1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F97S1 worth?
The government has obligated $22,318 on SPE2DR26F97S1.
Is contract SPE2DR26F97S1 an order under another contract?
Yes. SPE2DR26F97S1 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97S1 competed?
The extent of competition for SPE2DR26F97S1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award